HIGHLIGHTS
- who: Claudia Paret and colleagues from the Department of Pediatric Hematology/Oncology, Center for Pediatric and Adolescent Medicine, University Medical Center of the Gutenberg-University Mainz, Mainz, Germany have published the research: GD2 Expression in Medulloblastoma and Neuroblastoma for Personalized Immunotherapy: A Matter of Subtype, in the Journal: (JOURNAL)
- what: Residual lipid extracts from mouse liver used in this study had been collected for a previous study . The authors aimed to validate the predictive potential of the two-gene signature for the presence of GD2 by analyzing gene_expression of ST8SIA1 and B4GALNT1 by qRT-PCR . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.